Stocktoria
Embecta Corp. EMBC
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2022-03-21
Embecta Corp. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 62.6% | 65.5% | 66.9% | 68.6% | 68.7% |
| Operating margin | 22.4% | 14.9% | 19.8% | 27.4% | 42.2% |
| Net margin | 8.8% | 7.0% | 6.3% | 19.8% | 35.6% |
| FCF margin | 16.9% | 1.8% | 3.7% | 34.4% | 36.0% |
| Return on assets | 8.7% | 6.1% | 5.8% | 20.6% | 52.6% |
| Return on equity | -14.7% | -10.6% | -8.6% | -25.1% | 69.8% |
| Debt / equity | -2.15× | -2.13× | -1.94× | -1.79× | 0.00× |
| Current ratio | 2.41 | 2.03 | 2.12 | 2.21 | 1.78 |
| Revenue growth | -3.8% | 0.2% | -0.8% | -3.1% | — |
Source: SEC EDGAR filings · CIK 0001872789 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.